2.1. Ethical Approval
The study was conducted in accordance with the protocol authorized by the University of Anbar, Ethics Committee, Iraq. The Agricultural Research Directorate/Ministry of Agriculture/Iraq provided local, day-old laying chickens.
2.2. Study Period and Location
This study was conducted in the fields of the College of Agriculture University of Anbar, Department of Animal Production, for the period from 15/08/2022 to 28/02/2023. This study is complementary to a previous study, in which siRNA was also used and the local chicks were mixed with broiler chicks at one-day-old.
2.3. Experimental Study
The study used 120-hen chickens obtained at 22 weeks old. The chicks were divided into six treatments with 4 replicates for each treatment (20 chicks per treatment, 5 chicks per replicate) as follows: T1 – a negative control treatment consisting of local chicken; T2 – a positive control treatment consisting of commercial chicken; T3 – siRNA was used for silencing of the corticosterone hormone pathway to the CYP11B2 and CYP11B1 genes by injection in the jugular vein at the ages of 24 and 40 weeks; T4 – consisted of 25% commercial chicken + 75% local chicks; T5 – consisted of 50% commercial chicken + 50% local chicken; and T6 – consisted of 75% commercial chicken + 25% local chicken.
2.3.1. Chickens were obtained as follows:
The commercial chickens from ISA Brown were obtained from an Iraqi poultry production company, whilst the Iraqi wild-type chickens were obtained from local breeders.
2.3.2. The study took place
This study was conducted at the Department of Animal Production College of the Agriculture University of Anbar, Iraq, with data collection occurring for the period from 15/08/2022 to 28/02/2023.
2.3.3. Housing System Set-Up
housing close system
2.3.4. Stocking Density
20 chicks per treatment, 5 chicks per replicate, each replicate was kept in a 2.5 × 3 m area.
2.3.5. Feed Composition
The feed composition was according to the approved recommendation from the NRC.
2.3.5. Lighting Routine
The light regime was according to the approved recommendation from the ISA Brown index.
2.4. Habituation
Since the commercial layer hen (from ISA Brown) is relatively docile, it was chosen for training the wild-type, non-hybrid, local Iraqi type chickens.
For the experiment, 60 chicks (30 of each breed type) were housed in small groups with different proportions of each breed from immediately after hatching until the age of 22 weeks. This was to exploit the critical period when imprinting occurs, through which the chicks acquire behavioural characteristics from observing the other birds, according to Konrad Lorenz's theory. This process of imprinting is considered to be part of early learning, during the critical period, and is limited to the first few days after hatching, and is part of early learning to help birds remain stable (Tzschentke & Plagemann, 2006).
2.4.1. Procedure for habituation
Newly hatched wild local breed chicks were mixed with ISA Brown cross-bred commercial chickens in different ratios, to evaluate the extent to which the wild-type chickens acquired calm traits from the commercial chickens; or conversely that the commercial chickens acquired aggressive traits from the wild-type chickens. The proportion of each chicken type for each treatment groups were as follows:
T4: 25% commercial chicken + 75% local chicks
T5: 50% commercial chicken + 50% local chicks
T6: 75% commercial chicken + 25% local chicks
The focus was on the first days of hatching and taking advantage of the critical period, after which habituation procedures were carried out by excluding the ISA Brown commercial chicken birds for a week. Then they are returned to a recurring stimulus that repeats the habituation process, meaning that whenever the stimulus decreases, the stimulus is gone, as the motivation of trained chickens decreases, commercial chickens are reintroduced, which is a strong incentive for habituation is brought back again to complete habituation used to it stronger according to Pavlov's theory (Çevik, 2014). This condition continued until 21 weeks, after which the trained chickens were introduced to commercial chickens to begin the experiment at 22 weeks.
2.5. Small interfering RNA (siRNA)
Silencing of CYB11B1 and CYB11B2: The cDNA of each gene involved in the corticosterone manufacture pathway was obtained from NCBI. The coding sequence from the five ends at cap direction was revised to its opposite strand to be complementary for mRNA, then two siRNAs were delivered from Macrogene company (South Korea) in lyophilized form in high concentration with the following sequences:
CYP11B2f 5-acacctctgcctttgccctgagtgccat-3
CYP11B1r 5-ctaaagtcaaactcagccccacattcat-3
The siRNAs were dissolved in molecular-grade distilled water to get a final concentration of 500 pmol/ul . Each hen chicken in T3 of the study was injected into the jugular artery with 125 ul of the siRNA solution at 24 and 40 weeks of age. Procedures were according to the manufacturer's recommendations (Macrogene company; South Korea).
2.6. Blood Parameters
Blood samples were collected from three chickens from each replicate the from jugular vein at the age of 42 weeks and placed in heparinized (0.5 mL), EDTA (1 mL), and nonadditive (3 mL) blood collection tubes. After collection, blood samples were then placed in a tube containing Ethglene Diamine Tetra Acetic Acid Anticoagulant (EDTA). The remaining blood samples were placed in a centrifuge device at 3,000 rpm for 15 minutes for the purpose of plasma separation, then kept in the freezer at - 21°C to estimate the blood parameters of interest (Glucose, Cholesterol, Triglycerides, Total Protein, LDL, HDL, Globulin, Albumin and VLDL); as stated on testing kits purchased from Nanjing Jiancheng Institute of Bioengineering (Jiangsu, China) (SHEARER, 1979).
2.7 Hormone Concentration
After separating the serum from the cellular part of the blood, the plastic tubes containing the blood serum were transported, via a cool box, to the Al-Kak Specialized Scientific Laboratory, to conduct an ELISA test to measure the concentration of corticosterone in the blood serum using a testing kit. The ELISA test kit was produced by SunLong Biotech Co.,LTD, and was used according to the leaflet directions accompanying the kit (Rettenbacher et al., 2004).
2.8. Statistical analysis
This experiment was carried out using a Complete Randomized Design (CRD) and the data were analyzed by using the SAS program for statistical analysis (SAS, 2004). The means for each treatment were compared by using Duncan’s polynomial, using 0.05 and 0.01 significance levels to determine significant differences between the averages (Duncan, 1955).